Many people first learned about mRNA vaccines during the coronavirus pandemic, when the companies Pfizer-BioNTech and Moderna released their COVID-19 vaccines. The Pfizer-BioNTech shot was the first ...

In this podcast, recorded at the 2024 Immuno-Oncology 360º Summit, Dr Margaret Callahan, University of Connecticut, goes over the history of tumor vaccines in immuno-oncology, particularly the lessons ...

There's renewed debate on the future of mRNA vaccines, and Johns Hopkins researchers want to clear up some misconceptions around the shots. The mRNA vaccines gained attention during the height of ...

Programmable nucleic acid nanoparticles boost vaccine immune responses as effectively as standard adjuvants in mice while avoiding the autoimmune risks that limit existing alternatives. (Nanowerk ...

Patients with cancer who received mRNA-based COVID vaccines within 100 days of starting immune checkpoint therapy were twice as likely to be alive three years after beginning treatment, according to a ...